{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:11:16Z","timestamp":1774199476911,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.det.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T01:34:58Z","timestamp":1458696898000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Clinical Relevance of Antibiotic Resistance"],"prefix":"10.1016","volume":"34","author":[{"given":"James Q.","family":"Del Rosso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Zeichner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2015.12.003_bib1","series-title":"Comprehensive dermatologic therapy","first-page":"61","article-title":"Systemic antimicrobial agents","author":"Kim","year":"2013"},{"key":"10.1016\/j.det.2015.12.003_bib2","unstructured":"Sanchez G, Del Rosso JQ, Leyden JJ, et\u00a0al. Scientific panel on antibiotic therapy update. J Clin Aesthet Dermatol, in press."},{"issue":"2 Suppl 2","key":"10.1016\/j.det.2015.12.003_bib3","first-page":"5","article-title":"Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists","volume":"82","author":"Del Rosso","year":"2008","journal-title":"Cutis"},{"issue":"Suppl 6","key":"10.1016\/j.det.2015.12.003_bib4","first-page":"9","article-title":"Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance","volume":"79","author":"Leyden","year":"2007","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2015.12.003_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","article-title":"Antibiotic stewardship in dermatology: limiting antibiotic use in acne","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.det.2008.07.006","article-title":"Optimizing use of oral antibiotics in acne vulgaris","volume":"27","author":"Del Rosso","year":"2009","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2015.12.003_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne management","volume":"56","author":"Strauss","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2015.12.003_bib9","first-page":"1331","article-title":"A\u00a0call to limit antibiotic use in acne","volume":"12","author":"Thiboutout","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.12.003_bib10","first-page":"531","article-title":"American Acne and Rosacea Society rosacea medical management guidelines","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.det.2007.01.001","article-title":"Status report on antibiotic resistance: implications for the dermatologist","volume":"25","author":"Del Rosso","year":"2007","journal-title":"Dermatol Clin"},{"issue":"7","key":"10.1016\/j.det.2015.12.003_bib12","first-page":"724","article-title":"Antibiotic resistance: an editorial review with recommendations","volume":"10","author":"Rosen","year":"2011","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(06)70689-2","article-title":"Anti-infective research and development: problems, challenges, and solutions","volume":"7","author":"Bradley","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib14","first-page":"105","article-title":"Antibiotic resistance: what, why, where, when, and how?","volume":"116","author":"Sabtu","year":"2015","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.det.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/hs.2014.0083","article-title":"Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance","volume":"13","author":"Klepser","year":"2015","journal-title":"Health Secur"},{"issue":"Suppl 1","key":"10.1016\/j.det.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40121-015-0085-7","article-title":"Impact of antimicrobial stewardship program (ASP) on outcomes in patients with acute bacterial skin and skin structure infections (ABSSSIs) in an acute-tertiary care hospital","volume":"4","author":"Loo","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.det.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.139.4.467","article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne","volume":"139","author":"Levy","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib18","first-page":"585","article-title":"Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00128071-200304120-00002","article-title":"Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers","volume":"12","author":"Eady","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.1998.tb140250.x","article-title":"Systemic review of Propionibacterium acnes resistance to systemic antibiotics","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.det.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.1989.tb01399.x","article-title":"Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure","volume":"121","author":"Eady","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2008.07.001","article-title":"A\u00a0current review of topical benzoyl peroxide: new perspectives on formulation and utilization","volume":"27","author":"Tanghettti","year":"2009","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2015.12.003_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A\u00a0randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacyin the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.det.2015.12.003_bib25","first-page":"830","article-title":"The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach","volume":"11","author":"Leyden","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.det.2015.12.003_bib26","first-page":"22","article-title":"In-vivo effectiveness of adapalene 0.1%\/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant Propionibacterium acnes","volume":"4","author":"Leyden","year":"2011","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib27","series-title":"Acne vulgaris","first-page":"125","article-title":"Clinical implications of antibiotic resistance risk: risk of systemic infection from Staphylococcus and Streptococcus","author":"Bowe","year":"2011"},{"key":"10.1016\/j.det.2015.12.003_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"issue":"9560","key":"10.1016\/j.det.2015.12.003_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"The effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a ramdomized, double blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.det.2015.12.003_bib30","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/AAC.48.11.4183-4188.2004","article-title":"Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Berg","year":"2004","journal-title":"Antimicrob Ag Chemother"},{"issue":"5","key":"10.1016\/j.det.2015.12.003_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archderm.142.5.597","article-title":"Adapalene gel 0.1% as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blinded, follow-up of a recent combination study","volume":"142","author":"Thiboutot","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2015.12.003_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archderm.142.5.605","article-title":"Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study","volume":"142","author":"Leyden","year":"2006","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.12.003_bib33","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1365-2133.2011.10344.x","article-title":"A\u00a06-month maintenance therapy with adapalene-benzoyl peroxide gel prevents and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial","volume":"164","author":"Poulin","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2015.12.003_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"3","key":"10.1016\/j.det.2015.12.003_bib37","first-page":"16","article-title":"Advances in understanding and managing rosacea, part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","article-title":"Tetracycline actions relevant to rosacea treatment","volume":"22","author":"Korting","year":"2009","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.det.2015.12.003_bib39","first-page":"97","article-title":"Update on rosacea pathogenesis and correlation with medical therapeutic agents","volume":"78","author":"Del Rosso","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.det.2015.12.003_bib40","first-page":"673","article-title":"Rosacea: a review of current topical, systemic and light based therapies","volume":"144","author":"Kennedy Carney","year":"2009","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.det.2015.12.003_bib41","first-page":"21","article-title":"The potential role of microorganisms in the development of rosacea","volume":"9","author":"Lazaridou","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"4","key":"10.1016\/j.det.2015.12.003_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2015.12.003_bib43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase II clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2015.12.003_bib44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1902\/jop.2008.070375","article-title":"Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease","volume":"79","author":"Preshaw","year":"2008","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.det.2015.12.003_bib45","first-page":"664","article-title":"Anti-inflammatory dose doxycycline in the treatment of rosacea","volume":"8","author":"Del Rosso","year":"2009","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5 Suppl","key":"10.1016\/j.det.2015.12.003_bib46","first-page":"7","article-title":"An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads)","volume":"86","author":"Webster","year":"2010","journal-title":"Cutis"},{"issue":"5 Suppl","key":"10.1016\/j.det.2015.12.003_bib47","first-page":"26","article-title":"A\u00a0community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea","volume":"86","author":"Baldwin","year":"2010","journal-title":"Cutis"},{"issue":"5 Suppl","key":"10.1016\/j.det.2015.12.003_bib48","first-page":"16","article-title":"Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial","volume":"86","author":"Del Rosso","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.det.2015.12.003_bib49","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.12.003_bib50","first-page":"581","article-title":"Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study","volume":"14","author":"Moore","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"8","key":"10.1016\/j.det.2015.12.003_bib51","first-page":"20","volume":"4","author":"Del Rosso","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"10.1016\/j.det.2015.12.003_bib52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/429242","article-title":"Predicting antimicrobial resistance in invasive pneumococcal infections","volume":"40","author":"Vanderkooi","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2 Suppl 2","key":"10.1016\/j.det.2015.12.003_bib53","first-page":"3","article-title":"Update from the scientific panel on antibiotic use in dermatology: clinical considerations for the dermatologist","volume":"82","author":"Del Rosso","year":"2008","journal-title":"Cutis"},{"issue":"2","key":"10.1016\/j.det.2015.12.003_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2133.2001.03956.x","article-title":"Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan, and Australia","volume":"144","author":"Ross","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2015.12.003_bib55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.det.2015.12.003_bib56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finish Study Group for Antimicrobial Resistance","volume":"337","author":"Seppala","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2015.12.003_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jiac.2014.12.008","article-title":"The change of macrolide resistance rates in group A Streptococcus isolates from children between 2002 and 2013 in Asahikawa city","volume":"21","author":"Sakata","year":"2015","journal-title":"J Infect Chemother"},{"issue":"9","key":"10.1016\/j.det.2015.12.003_bib58","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/383309","article-title":"Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001","volume":"38","author":"Bergman","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.134.1.49","article-title":"Bacteriology of inflamed and uninflamed epidermal inclusion cysts","volume":"134","author":"Diven","year":"1998","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2015.12.003_bib60","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/cem.2014.52","article-title":"The role of adjunctive antibiotics in the treatment of skin and soft tissue abscesses: a systematic review and meta-analysis","volume":"17","author":"Fahimi","year":"2015","journal-title":"CJEM"},{"issue":"1","key":"10.1016\/j.det.2015.12.003_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.det.2008.07.003","article-title":"When antibiotics are unnecessary","volume":"27","author":"Hirschmann","year":"2009","journal-title":"Dermatol Clin"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351500159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351500159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:05:17Z","timestamp":1600362317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351500159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S073386351500159X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.12.003","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Relevance of Antibiotic Resistance","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}